Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Mirum Pharmaceuticals (MIRM) Receivables - Net (2021 - 2025)

Mirum Pharmaceuticals has reported Receivables - Net over the past 5 years, most recently at $123.3 million for Q4 2025.

  • Quarterly results put Receivables - Net at $123.3 million for Q4 2025, up 57.54% from a year ago — trailing twelve months through Dec 2025 was $123.3 million (up 57.54% YoY), and the annual figure for FY2025 was $123.3 million, up 57.54%.
  • Receivables - Net for Q4 2025 was $123.3 million at Mirum Pharmaceuticals, up from $107.1 million in the prior quarter.
  • Over the last five years, Receivables - Net for MIRM hit a ceiling of $123.3 million in Q4 2025 and a floor of $400000.0 in Q3 2021.
  • Median Receivables - Net over the past 5 years was $51.4 million (2023), compared with a mean of $52.1 million.
  • Biggest five-year swings in Receivables - Net: surged 3984.25% in 2022 and later rose 15.18% in 2024.
  • Mirum Pharmaceuticals' Receivables - Net stood at $3.3 million in 2021, then soared by 634.44% to $24.0 million in 2022, then surged by 183.27% to $68.0 million in 2023, then increased by 15.18% to $78.3 million in 2024, then soared by 57.54% to $123.3 million in 2025.
  • The last three reported values for Receivables - Net were $123.3 million (Q4 2025), $107.1 million (Q3 2025), and $106.8 million (Q2 2025) per Business Quant data.